These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19176539)

  • 1. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Hawkins NM; Huang Z; Pieper KS; Solomon SD; Kober L; Velazquez EJ; Swedberg K; Pfeffer MA; McMurray JJ; Maggioni AP;
    Eur J Heart Fail; 2009 Mar; 11(3):292-8. PubMed ID: 19176539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valsartan in acute myocardial infarction trial (VALIANT): rationale and design.
    Pfeffer MA; McMurray J; Leizorovicz A; Maggioni AP; Rouleau JL; Van De Werf F; Henis M; Neuhart E; Gallo P; Edwards S; Sellers MA; Velazquez E; Califf R
    Am Heart J; 2000 Nov; 140(5):727-50. PubMed ID: 11054617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial.
    Yerra L; Anavekar N; Skali H; Zelenkofske S; Velazquez E; McMurray J; Pfeffer M; Solomon SD
    Heart Rhythm; 2006 Mar; 3(3):313-6. PubMed ID: 16500304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
    Stephenson K; Skali H; McMurray JJ; Velazquez EJ; Aylward PG; Kober L; Van de Werf F; White HD; Pieper KS; Califf RM; Solomon SD; Pfeffer MA
    Heart Rhythm; 2007 Mar; 4(3):308-13. PubMed ID: 17341394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
    Shamshad F; Kenchaiah S; Finn PV; Soler-Soler J; McMurray JJ; Velazquez EJ; Maggioni AP; Califf RM; Swedberg K; Kober L; Belenkov Y; Varshavsky S; Pfeffer MA; Solomon SD;
    Am Heart J; 2010 Jul; 160(1):145-51. PubMed ID: 20598985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
    Verma A; Meris A; Skali H; Ghali JK; Arnold JM; Bourgoun M; Velazquez EJ; McMurray JJ; Kober L; Pfeffer MA; Califf RM; Solomon SD
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):582-91. PubMed ID: 19356485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
    Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
    J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of the VALIANT trial in post-myocardial infarction].
    Solignac M
    Presse Med; 2004 Jun; 33(11):755-8. PubMed ID: 15257233
    [No Abstract]   [Full Text] [Related]  

  • 12. VALIANT (VALsartan In Acute myocardial iNfarcTion) trial.
    Maggioni AP; Fabbri G
    Expert Opin Pharmacother; 2005 Mar; 6(3):507-12. PubMed ID: 15794740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
    N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
    Lewis EF; Li Y; Pfeffer MA; Solomon SD; Weinfurt KP; Velazquez EJ; Califf RM; Rouleau JL; Kober L; White HD; Schulman KA; Reed SD
    JACC Heart Fail; 2014 Apr; 2(2):159-65. PubMed ID: 24720924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
    Thune JJ; Signorovitch JE; Kober L; McMurray JJ; Swedberg K; Rouleau J; Maggioni A; Velazquez E; Califf R; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2011 Feb; 13(2):148-53. PubMed ID: 21037250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
    Prisant LM; Thomas KL; Lewis EF; Huang Z; Francis GS; Weaver WD; Pfeffer MA; McMurray JJ; Califf RM; Velazquez EJ
    J Am Coll Cardiol; 2008 May; 51(19):1865-71. PubMed ID: 18466801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
    Shin SH; Hung CL; Uno H; Hassanein AH; Verma A; Bourgoun M; Køber L; Ghali JK; Velazquez EJ; Califf RM; Pfeffer MA; Solomon SD;
    Circulation; 2010 Mar; 121(9):1096-103. PubMed ID: 20176989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
    Pfeffer MA; McMurray JJ; Velazquez EJ; Rouleau JL; Køber L; Maggioni AP; Solomon SD; Swedberg K; Van de Werf F; White H; Leimberger JD; Henis M; Edwards S; Zelenkofske S; Sellers MA; Califf RM;
    N Engl J Med; 2003 Nov; 349(20):1893-906. PubMed ID: 14610160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.